NCT02589236 Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Status COMPLETED Phase PHASE2
NCT02565914 A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Participants With Cystic Fibrosis Who Have an F508del-CFTR Mutation Status COMPLETED Phase PHASE3
NCT02564393 Induction of Neutrophilic Traps ( NETs ) by the Environment and Infectious Inflammatory Lung Cystic Fibrosis Status COMPLETED Phase N/A
NCT02564354 Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation Status COMPLETED Phase PHASE1
NCT02552043 Video Game Exercise Effectiveness of a Domiciliary Pulmonary Rehabilitation Program in Cystic Fibrosis Patients Status COMPLETED Phase NA
NCT02547116 Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis Status WITHDRAWN Phase PHASE4
NCT02544451 Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor Status COMPLETED Phase PHASE3
NCT02535130 Evaluation of Nebulization and Positive Expiratory Pressure Combination Status UNKNOWN Phase NA
NCT02532764 Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients Status COMPLETED Phase PHASE1/PHASE2
NCT02526004 Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified Status COMPLETED Phase NA
NCT02518672 Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC) Status TERMINATED Phase PHASE2
NCT02516410 A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation Status COMPLETED Phase PHASE3
NCT02514473 A Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects With CF, Homozygous for the F508del-CFTR Mutation Status COMPLETED Phase PHASE3
NCT02508207 A Phase 2 Study to Evaluate Effects of VX-661/Ivacaftor on Lung and Extrapulmonary Systems in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation Status COMPLETED Phase PHASE2